Delivery Order SPE2DB25D7067-SPE2DB25FSVYW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,965.42 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $3,025.64. This non-set-aside contract was awarded on August 1, 2025, under a firm fixed price arrangement, with an ultimate completion date of August 4, 2025. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $33,003.17 to AmerisourceBergen Drug Corp for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 22, 2025. The award is being performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Truvada 200 mg-300 mg tablets. The $8,241.75 delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Truvada 200 mg-300 mg tablets. The contract has a ceiling value of $7,579.20 and a completion date of July 10, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Truvada 200 mg-300 mg tablets. The contract has a ceiling value of $14,112.60 and an ultimate completion date of March 6, 2025. The contract is a delivery order with a firm fixed price pricing type. AmerisourceBergen is the prime contractor, and there is no indication of any major subcontractors. This award does not have a set-aside...
- This is a $19,285.87 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Truvada 200 mg-300 mg tablets, with a completion date of April 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,553.56 contract is for the delivery of the pharmaceutical product Truvada 200 mg-300 mg tablets. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract, valued at $1,214.81, is for the delivery of TRUVADA 200 MG-300 MG TABLET, a brand name medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,842.20, is for the supply of Truvada 200 mg-300 mg tablets and has a period of performance through March 11, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVYWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Truvada 200 mg-300 mg tablets in quantities of 30 units, with a ceiling value of $13,263.60 and a firm fixed price structure. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company has demonstrated significant capability in fulfilling federal pharmaceutical requirements through multiple competitive awards and serves as a critical vendor for the Defense Health Agency and U.S. Coast Guard. Performance of this delivery order will occur at the company's Conshohocken, Pennsylvania location, with an ultimate completion date of September 15, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 9/12/25 |